P1113: COMPARATIVE EFFICACY OF ZANUBRUTINIB (ZANU) VERSUS RITUXIMAB (RTX) IN RELAPSED MARGINAL ZONE LYMPHOMA (MZL): MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)
Catherine Thieblemont,
Kaijun Wang,
Sam Keeping,
Ina Zhang,
Keri Yang,
Boxiong Tang,
Leyla Mohseninejad
Affiliations
Catherine Thieblemont
1 Hôpital Saint-Louis, Paris, France
Kaijun Wang
2 BeiGene USA, Inc., San Mateo, CA, USA and BeiGene Switzerland GmbH, Basel, Switzerland
Sam Keeping
3 PRECISIONheor, Vancouver, Canada
Ina Zhang
3 PRECISIONheor, Vancouver, Canada
Keri Yang
2 BeiGene USA, Inc., San Mateo, CA, USA and BeiGene Switzerland GmbH, Basel, Switzerland
Boxiong Tang
2 BeiGene USA, Inc., San Mateo, CA, USA and BeiGene Switzerland GmbH, Basel, Switzerland
Leyla Mohseninejad
2 BeiGene USA, Inc., San Mateo, CA, USA and BeiGene Switzerland GmbH, Basel, Switzerland